[3] Beyond its primary indications, tirzepatide is not approved for type 1 diabetes
However, it remains much lower than the mortality associated with using LVAD as destination therapy, where 1-year mortality can reach up to 48% [80]
In addition, GLP-1 users and non-users agree its OK to occasionally treat yourself to a baked snack or dessert, with around 90% of those polled in each group believing baked treats/snacks can be a great reward or escape
Analyzing the historical market, estimating the current market, and forecasting the future market of the global GLP-1 Analogues market were the three major steps undertaken to create and analyze the adoption of GLP-1 Analogues in major regions globally
reuteri , and Akkermansia muciniphila (Weng et al., 2024)
and Aldhwayan, M